Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: A north American perspective

Screening for Long-Term Cardiac Status During Cancer Treatment

(2012) Steven E. Lipshultz et al.   Circulation-Cardiovascular Imaging

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

(2012) Heloisa Sawaya et al.   Circulation-Cardiovascular Imaging

Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy

(2012) Steven E. Lipshultz et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes

(2012) Steven E. Lipshultz et al.   JOURNAL OF CLINICAL ONCOLOGY

Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging

(2012) Gregory T. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer

(2011) Cornelia A.J. Brouwer et al.   EUROPEAN JOURNAL OF CANCER

Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

(2011) Javier G. Blanco et al.   JOURNAL OF CLINICAL ONCOLOGY

Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors

(2011) Ibraheem Abosoudah et al.   PEDIATRIC BLOOD & CANCER

Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: Retrospective cohort study in a single centre in the United Kingdom

(2011) Petra Temming et al.   PEDIATRIC BLOOD & CANCER

Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy

(2010) Y.-f. Cheung et al.   HEART

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

(2010) Malcolm A. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Should anthracyclines and dexrazoxane be used for children with cancer?

(2010) Elvira C van Dalen et al.   LANCET ONCOLOGY

Cardiac dysfunction in severe sepsis and septic shock

(2009) Sergio L Zanotti-Cavazzoni et al.   Current Opinion in Critical Care

Anthracycline Dose Intensification in Acute Myeloid Leukemia

(2009) Hugo F. Fernandez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane

(2008) Elly V. Barry et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracycline Cardiotoxicity: From Bench to Bedside

(2008) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in 5- and 10-year Survival After Diagnosis with Childhood Hematologic Malignancies in the United States, 1990–2004

(2008) Dianne Pulte et al.   JNCI-Journal of the National Cancer Institute